CXCL13 and COVID-19: In line with these studies, we observed increased serum CXCL13 in patients with severe COVID-19 compared with individuals with OTD, supporting the hypothesis that elevated levels of CXCL13 may be harmful and responsible for severe inflammation and the promotion of lung fibrosis in this setting.